Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone for PPROM Management
NCT01050647Phase 2Completed
- Sponsor
- Stanford University
- Start
- Feb 2010
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxyprogesterone caproate in preterm premature rupture of membranes (pPROM), sponsored by Stanford University. Started Feb 2010; status: completed.
02
Drugs
hydroxyprogesterone caproate
03
Conditions
preterm premature rupture of membranes (pPROM)
Beyond the preview
Go deeper on NCT01050647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01050647.